Histone deacetylase-high mobility group box-1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells

Hypaconitine is an active component of Aconitum carmichaelii Debx, a Chinese medicinal herb for the treatment of cardiovascular diseases, but the mechanism underlying its effect remains elusive. In this study, we found that hypaconitine, rather than aconitum alkaloids in A. carmichaelii (e.g. aconit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental biology and medicine (Maywood, N.J.) N.J.), 2017-03, Vol.242 (5), p.527-535
Hauptverfasser: Bai, Ye, Du, Shaohui, Li, Fei, Huang, Fengyuan, Deng, Rudong, Zhou, Jianhong, Chen, Dongfeng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 535
container_issue 5
container_start_page 527
container_title Experimental biology and medicine (Maywood, N.J.)
container_volume 242
creator Bai, Ye
Du, Shaohui
Li, Fei
Huang, Fengyuan
Deng, Rudong
Zhou, Jianhong
Chen, Dongfeng
description Hypaconitine is an active component of Aconitum carmichaelii Debx, a Chinese medicinal herb for the treatment of cardiovascular diseases, but the mechanism underlying its effect remains elusive. In this study, we found that hypaconitine, rather than aconitum alkaloids in A. carmichaelii (e.g. aconitine, mesaconitine and benzoylaconitine), prevented endothelial cells from damage due to oxidized low-density lipoprotein (oxLDL) challenge. Cleaved caspase 3 expression in endothelial cells was up-regulated by oxLDL and markedly attenuated by hypaconitine, suggesting that hypaconitine inhibited the oxLDL-induced cell apoptosis. Microarray analysis revealed that histone deacetylase 3 (HDAC3) was significantly increased by hypaconitine. The cytoplasmic relocation and extracellular release of high-mobility group box 1 (HMGB1, an HDAC3 downstream effector) in endothelial cells were significantly increased by oxLDL and markedly decreased by hypaconitine. The effect of hypaconitine on the oxLDL-induced apoptosis and HMGB1 release in endothelial cells was significantly reduced by the suppression of HDAC3 by siRNA or a specific inhibitor. Thus, this study proves that the histone deacetylase-HMGB1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells. Our findings are of therapeutic significance and provide the potential of hypaconitine exploitation. Impact statement First, our study shows the antiapoptosis effect of Aconitum carmichaelii and its active component hypaconitine on endothelial cells. It may provide new strategies for the treatment of diseases involving endothelium damage. Second, this finding indicates the function of hypaconitine in regulating HDAC3-HMGB1 pathway, which suggests a new anti-inflammatory therapy. Third, due to its poisonousness, A. carmichaelii is always used with caution in clinics. Thus, the identification of hypaconitine as an active component of A. carmichaelii could contribute to the development of toxicity-decreasing procedure for A. carmichaelii.
doi_str_mv 10.1177/1535370216685433
format Article
fullrecord <record><control><sourceid>sage_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5367659</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1535370216685433</sage_id><sourcerecordid>10.1177_1535370216685433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-8445844bb1a7080a117bb18c90406d0937084427a184c799c3ebbb4a1454929f3</originalsourceid><addsrcrecordid>eNp1kc1q3TAQhUVoyV-zz6roBZxIlmRbm0IJbRMIZJOszUieayv4WkLSbWvIw1fhJqEtZCE0zJnzDTNDyDlnF5y37SVXQomW1bxpOiWFOCDHz6lKNFp_eI2LfkROUnpkjKu2bg7JUd0x1SipjsnTtUvZL0gHBIt5nSFhNblxoltv3OzySsfod4Ea_7viNECefsFKM8QRMw7UrHRaA1i_uOwKJu1CiJgSJponpBB8yD65RP2G4jL4kpwdzNTiPKdP5OMG5oRnL_8pefj-7f7qurq9-3Fz9fW2slLIXHVSqvKM4dCyjkEZvcSd1UyyZmC6TFjkugXeSdtqbQUaYyRwqaSu9Uacki97btiZLQ4Wlxxh7kN0W4hr78H1_yqLm_rR_-yVaNpG6QJge4CNPqWImzcvZ_3zJfr_L1Esn__u-WZ4XX0pqPYFCUbsH_0uLmUH7wP_AFTuk8M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Histone deacetylase-high mobility group box-1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SAGE Complete</source><source>PubMed Central</source><creator>Bai, Ye ; Du, Shaohui ; Li, Fei ; Huang, Fengyuan ; Deng, Rudong ; Zhou, Jianhong ; Chen, Dongfeng</creator><creatorcontrib>Bai, Ye ; Du, Shaohui ; Li, Fei ; Huang, Fengyuan ; Deng, Rudong ; Zhou, Jianhong ; Chen, Dongfeng</creatorcontrib><description>Hypaconitine is an active component of Aconitum carmichaelii Debx, a Chinese medicinal herb for the treatment of cardiovascular diseases, but the mechanism underlying its effect remains elusive. In this study, we found that hypaconitine, rather than aconitum alkaloids in A. carmichaelii (e.g. aconitine, mesaconitine and benzoylaconitine), prevented endothelial cells from damage due to oxidized low-density lipoprotein (oxLDL) challenge. Cleaved caspase 3 expression in endothelial cells was up-regulated by oxLDL and markedly attenuated by hypaconitine, suggesting that hypaconitine inhibited the oxLDL-induced cell apoptosis. Microarray analysis revealed that histone deacetylase 3 (HDAC3) was significantly increased by hypaconitine. The cytoplasmic relocation and extracellular release of high-mobility group box 1 (HMGB1, an HDAC3 downstream effector) in endothelial cells were significantly increased by oxLDL and markedly decreased by hypaconitine. The effect of hypaconitine on the oxLDL-induced apoptosis and HMGB1 release in endothelial cells was significantly reduced by the suppression of HDAC3 by siRNA or a specific inhibitor. Thus, this study proves that the histone deacetylase-HMGB1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells. Our findings are of therapeutic significance and provide the potential of hypaconitine exploitation. Impact statement First, our study shows the antiapoptosis effect of Aconitum carmichaelii and its active component hypaconitine on endothelial cells. It may provide new strategies for the treatment of diseases involving endothelium damage. Second, this finding indicates the function of hypaconitine in regulating HDAC3-HMGB1 pathway, which suggests a new anti-inflammatory therapy. Third, due to its poisonousness, A. carmichaelii is always used with caution in clinics. Thus, the identification of hypaconitine as an active component of A. carmichaelii could contribute to the development of toxicity-decreasing procedure for A. carmichaelii.</description><identifier>ISSN: 1535-3702</identifier><identifier>EISSN: 1535-3699</identifier><identifier>DOI: 10.1177/1535370216685433</identifier><identifier>PMID: 28056545</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Aconitine - analogs &amp; derivatives ; Aconitine - pharmacology ; Aconitum - chemistry ; Apoptosis - drug effects ; Apoptosis - physiology ; Blotting, Western ; Cell Line ; Endothelial Cells - drug effects ; Endothelial Cells - physiology ; Enzyme-Linked Immunosorbent Assay ; Histone Deacetylases - drug effects ; Histone Deacetylases - physiology ; HMGB1 Protein - drug effects ; HMGB1 Protein - physiology ; Humans ; Oligonucleotide Array Sequence Analysis ; Original Research ; Real-Time Polymerase Chain Reaction ; Signal Transduction - drug effects ; Signal Transduction - physiology</subject><ispartof>Experimental biology and medicine (Maywood, N.J.), 2017-03, Vol.242 (5), p.527-535</ispartof><rights>2017 by the Society for Experimental Biology and Medicine</rights><rights>2017 by the Society for Experimental Biology and Medicine 2017 The Society for Experimental Biology and Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-8445844bb1a7080a117bb18c90406d0937084427a184c799c3ebbb4a1454929f3</citedby><cites>FETCH-LOGICAL-c434t-8445844bb1a7080a117bb18c90406d0937084427a184c799c3ebbb4a1454929f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367659/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367659/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,21798,27901,27902,43597,43598,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28056545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bai, Ye</creatorcontrib><creatorcontrib>Du, Shaohui</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Huang, Fengyuan</creatorcontrib><creatorcontrib>Deng, Rudong</creatorcontrib><creatorcontrib>Zhou, Jianhong</creatorcontrib><creatorcontrib>Chen, Dongfeng</creatorcontrib><title>Histone deacetylase-high mobility group box-1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells</title><title>Experimental biology and medicine (Maywood, N.J.)</title><addtitle>Exp Biol Med (Maywood)</addtitle><description>Hypaconitine is an active component of Aconitum carmichaelii Debx, a Chinese medicinal herb for the treatment of cardiovascular diseases, but the mechanism underlying its effect remains elusive. In this study, we found that hypaconitine, rather than aconitum alkaloids in A. carmichaelii (e.g. aconitine, mesaconitine and benzoylaconitine), prevented endothelial cells from damage due to oxidized low-density lipoprotein (oxLDL) challenge. Cleaved caspase 3 expression in endothelial cells was up-regulated by oxLDL and markedly attenuated by hypaconitine, suggesting that hypaconitine inhibited the oxLDL-induced cell apoptosis. Microarray analysis revealed that histone deacetylase 3 (HDAC3) was significantly increased by hypaconitine. The cytoplasmic relocation and extracellular release of high-mobility group box 1 (HMGB1, an HDAC3 downstream effector) in endothelial cells were significantly increased by oxLDL and markedly decreased by hypaconitine. The effect of hypaconitine on the oxLDL-induced apoptosis and HMGB1 release in endothelial cells was significantly reduced by the suppression of HDAC3 by siRNA or a specific inhibitor. Thus, this study proves that the histone deacetylase-HMGB1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells. Our findings are of therapeutic significance and provide the potential of hypaconitine exploitation. Impact statement First, our study shows the antiapoptosis effect of Aconitum carmichaelii and its active component hypaconitine on endothelial cells. It may provide new strategies for the treatment of diseases involving endothelium damage. Second, this finding indicates the function of hypaconitine in regulating HDAC3-HMGB1 pathway, which suggests a new anti-inflammatory therapy. Third, due to its poisonousness, A. carmichaelii is always used with caution in clinics. Thus, the identification of hypaconitine as an active component of A. carmichaelii could contribute to the development of toxicity-decreasing procedure for A. carmichaelii.</description><subject>Aconitine - analogs &amp; derivatives</subject><subject>Aconitine - pharmacology</subject><subject>Aconitum - chemistry</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - physiology</subject><subject>Blotting, Western</subject><subject>Cell Line</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - physiology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Histone Deacetylases - drug effects</subject><subject>Histone Deacetylases - physiology</subject><subject>HMGB1 Protein - drug effects</subject><subject>HMGB1 Protein - physiology</subject><subject>Humans</subject><subject>Oligonucleotide Array Sequence Analysis</subject><subject>Original Research</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><issn>1535-3702</issn><issn>1535-3699</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1q3TAQhUVoyV-zz6roBZxIlmRbm0IJbRMIZJOszUieayv4WkLSbWvIw1fhJqEtZCE0zJnzDTNDyDlnF5y37SVXQomW1bxpOiWFOCDHz6lKNFp_eI2LfkROUnpkjKu2bg7JUd0x1SipjsnTtUvZL0gHBIt5nSFhNblxoltv3OzySsfod4Ea_7viNECefsFKM8QRMw7UrHRaA1i_uOwKJu1CiJgSJponpBB8yD65RP2G4jL4kpwdzNTiPKdP5OMG5oRnL_8pefj-7f7qurq9-3Fz9fW2slLIXHVSqvKM4dCyjkEZvcSd1UyyZmC6TFjkugXeSdtqbQUaYyRwqaSu9Uacki97btiZLQ4Wlxxh7kN0W4hr78H1_yqLm_rR_-yVaNpG6QJge4CNPqWImzcvZ_3zJfr_L1Esn__u-WZ4XX0pqPYFCUbsH_0uLmUH7wP_AFTuk8M</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Bai, Ye</creator><creator>Du, Shaohui</creator><creator>Li, Fei</creator><creator>Huang, Fengyuan</creator><creator>Deng, Rudong</creator><creator>Zhou, Jianhong</creator><creator>Chen, Dongfeng</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20170301</creationdate><title>Histone deacetylase-high mobility group box-1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells</title><author>Bai, Ye ; Du, Shaohui ; Li, Fei ; Huang, Fengyuan ; Deng, Rudong ; Zhou, Jianhong ; Chen, Dongfeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-8445844bb1a7080a117bb18c90406d0937084427a184c799c3ebbb4a1454929f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aconitine - analogs &amp; derivatives</topic><topic>Aconitine - pharmacology</topic><topic>Aconitum - chemistry</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - physiology</topic><topic>Blotting, Western</topic><topic>Cell Line</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - physiology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Histone Deacetylases - drug effects</topic><topic>Histone Deacetylases - physiology</topic><topic>HMGB1 Protein - drug effects</topic><topic>HMGB1 Protein - physiology</topic><topic>Humans</topic><topic>Oligonucleotide Array Sequence Analysis</topic><topic>Original Research</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bai, Ye</creatorcontrib><creatorcontrib>Du, Shaohui</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Huang, Fengyuan</creatorcontrib><creatorcontrib>Deng, Rudong</creatorcontrib><creatorcontrib>Zhou, Jianhong</creatorcontrib><creatorcontrib>Chen, Dongfeng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental biology and medicine (Maywood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bai, Ye</au><au>Du, Shaohui</au><au>Li, Fei</au><au>Huang, Fengyuan</au><au>Deng, Rudong</au><au>Zhou, Jianhong</au><au>Chen, Dongfeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histone deacetylase-high mobility group box-1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells</atitle><jtitle>Experimental biology and medicine (Maywood, N.J.)</jtitle><addtitle>Exp Biol Med (Maywood)</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>242</volume><issue>5</issue><spage>527</spage><epage>535</epage><pages>527-535</pages><issn>1535-3702</issn><eissn>1535-3699</eissn><abstract>Hypaconitine is an active component of Aconitum carmichaelii Debx, a Chinese medicinal herb for the treatment of cardiovascular diseases, but the mechanism underlying its effect remains elusive. In this study, we found that hypaconitine, rather than aconitum alkaloids in A. carmichaelii (e.g. aconitine, mesaconitine and benzoylaconitine), prevented endothelial cells from damage due to oxidized low-density lipoprotein (oxLDL) challenge. Cleaved caspase 3 expression in endothelial cells was up-regulated by oxLDL and markedly attenuated by hypaconitine, suggesting that hypaconitine inhibited the oxLDL-induced cell apoptosis. Microarray analysis revealed that histone deacetylase 3 (HDAC3) was significantly increased by hypaconitine. The cytoplasmic relocation and extracellular release of high-mobility group box 1 (HMGB1, an HDAC3 downstream effector) in endothelial cells were significantly increased by oxLDL and markedly decreased by hypaconitine. The effect of hypaconitine on the oxLDL-induced apoptosis and HMGB1 release in endothelial cells was significantly reduced by the suppression of HDAC3 by siRNA or a specific inhibitor. Thus, this study proves that the histone deacetylase-HMGB1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells. Our findings are of therapeutic significance and provide the potential of hypaconitine exploitation. Impact statement First, our study shows the antiapoptosis effect of Aconitum carmichaelii and its active component hypaconitine on endothelial cells. It may provide new strategies for the treatment of diseases involving endothelium damage. Second, this finding indicates the function of hypaconitine in regulating HDAC3-HMGB1 pathway, which suggests a new anti-inflammatory therapy. Third, due to its poisonousness, A. carmichaelii is always used with caution in clinics. Thus, the identification of hypaconitine as an active component of A. carmichaelii could contribute to the development of toxicity-decreasing procedure for A. carmichaelii.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>28056545</pmid><doi>10.1177/1535370216685433</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1535-3702
ispartof Experimental biology and medicine (Maywood, N.J.), 2017-03, Vol.242 (5), p.527-535
issn 1535-3702
1535-3699
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5367659
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SAGE Complete; PubMed Central
subjects Aconitine - analogs & derivatives
Aconitine - pharmacology
Aconitum - chemistry
Apoptosis - drug effects
Apoptosis - physiology
Blotting, Western
Cell Line
Endothelial Cells - drug effects
Endothelial Cells - physiology
Enzyme-Linked Immunosorbent Assay
Histone Deacetylases - drug effects
Histone Deacetylases - physiology
HMGB1 Protein - drug effects
HMGB1 Protein - physiology
Humans
Oligonucleotide Array Sequence Analysis
Original Research
Real-Time Polymerase Chain Reaction
Signal Transduction - drug effects
Signal Transduction - physiology
title Histone deacetylase-high mobility group box-1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T22%3A38%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histone%20deacetylase-high%20mobility%20group%20box-1%20pathway%20targeted%20by%20hypaconitine%20suppresses%20the%20apoptosis%20of%20endothelial%20cells&rft.jtitle=Experimental%20biology%20and%20medicine%20(Maywood,%20N.J.)&rft.au=Bai,%20Ye&rft.date=2017-03-01&rft.volume=242&rft.issue=5&rft.spage=527&rft.epage=535&rft.pages=527-535&rft.issn=1535-3702&rft.eissn=1535-3699&rft_id=info:doi/10.1177/1535370216685433&rft_dat=%3Csage_pubme%3E10.1177_1535370216685433%3C/sage_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28056545&rft_sage_id=10.1177_1535370216685433&rfr_iscdi=true